6th Annual Comprehensive Neurotoxin Course for Neurological Conditions

6th Annual Comprehensive Neurotoxin Course for Neurological Conditions is organized by Cleveland Clinic Foundation Center for Continuing Education and would be held during Sep 6 – Nov 11, 2017 at Cleveland Clinic Main Campus, Cleveland, Ohio, United States Of America.

The target audience for this medical event forneurologists, physiatrists, residents, fellows and nurse practitioners. This CME Conference has been approved with a maximum offor a maximum of 1.5 AMA PRA Category 1 Credits for Webinar and 7.0 AMA PRA Category 1 Credits for Live Conference.

Course Description

With the ever-growing therapeutic indications for toxin treatment, increasing numbers of available toxins, and the potential dangers and pitfalls if toxin injections are performed sub-optimally, there is a clear need for a comprehensive training of toxin injection. The clear educational need is for a thorough and intensive training that incorporates balanced and comprehensive didactic lectures, the opportunity to ask questions on uncertain areas, live demonstrations, and true assessment of understanding of concepts and readiness for injection.

This comprehensive program is unique in its duration, breadth, and content delivery. It consists of eight computer-based sessions held live on Wednesdays from September to October, that allows interaction with faculty and modular examinations. The series culminates with a full day live program held in Cleveland that features toxin injection demonstrations on actual patients. The faculty are North American thought-leaders in dystonia and toxin injections with reputations for being exemplary educators. Participants may register for the eight webinar series or the full day live program or both. Special discount for those who register for both.

Conference Objectives are :

Overall objective:

To provide the practicing clinician or clinician-in-training the necessary knowledge needed to competently utilize all types botulinum toxins for various neurological indications.

Specific objectives:

• Describe the fundamental pharmacology of botulinum toxin, its history, mechanisms of action, duration and onset of action, potential side effects, contraindications, and clinical indications.
• List the four toxin types available in North America and summarize their differences and similarities in clinical response, dosing, side effects, preparation, and administration.
• Review the different therapeutic uses of botulinum toxins in neurological disorders, both FDA-approved indications (eg, cervical dystonia, blepharospasms, headache, upper limb spasticity) and off-label uses (eg, limb spasticity and dystonia, hemifacial spasms, oromandibular dystonia, spasmodic dysphonia, sialorrhea, tics, tremor).
• Describe the proper administration of all types of botulinum toxins including anatomic localization, target and muscle selection, use of electromyographic and ultrasound guidance, and injection techniques.
• Illustrate the proper and ethical process of consent, preauthorization, billing, and coding for botulinum toxin use.

A webinar series + full day live program
8 webinars:
Wednesday evenings from
September 6–October 25, 2017
Full day live program:
Friday, November 10, 2017

Additional details will be posted as soon as they are available.